Provided by Tiger Fintech (Singapore) Pte. Ltd.

WUXI BIO

37.660
-1.320-3.39%
Volume:52.00M
Turnover:1.98B
Market Cap:153.69B
PE:41.89
High:39.380
Open:39.100
Low:37.420
Close:38.980
52wk High:39.380
52wk Low:10.360
Shares:4.08B
HK Float Shares:4.08B
Volume Ratio:0.79
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.899
ROE:10.50%
ROA:5.89%
PB:3.13
PE(LYR):41.89
PS:7.01

Loading ...

CICC Maintains Outperform Rating for WUXI BIO (02269), Raises Target Price to HK$36

Stock News
·
Aug 21

BUZZ-WuXi Biologics rises most in 3 weeks on robust first-half results

Reuters
·
Aug 20

BRIEF-Wuxi Biologics Posts H1 Net Income RMB 2,756.6 Million

Reuters
·
Aug 20

WuXi Biologics's Profit Surges 56% in H1

MT Newswires Live
·
Aug 19

WuXi Biologics Reports Solid 2025 Interim Results

THOMSON REUTERS
·
Aug 19

WuXi Biologics H1 Adjusted Net Income RMB 2,840 Million

THOMSON REUTERS
·
Aug 19

WUXI BIO (02269) Achieves Record High New Projects in H1, Late-Stage and Commercial Production Revenue Surges 24.9% YoY

Deep News
·
Aug 19

WUXI BIO (02269) Announces Interim Results with Net Profit Attributable to Owners of Approximately 2.339 Billion Yuan, Up 56% Year-on-Year

Stock News
·
Aug 19

WuXi Biologics H1 Net Income RMB 2,756.6 Million

THOMSON REUTERS
·
Aug 19

Wuxi Biologics (Cayman) Stock Slides 3.9% in Hong Kong

Dow Jones
·
Aug 19

WuXi Biologics Ireland Facility Receives Ema Approval for Commercial Manufacturing of Innovative Biologic

THOMSON REUTERS
·
Aug 18

DIARY-Hong Kong corporate earnings week ahead

Reuters
·
Aug 15

Hong Kong Stock Movement | WuXi Biologics (02269) Rises Over 3% Intraday After Announcing WuXiUP™ Successfully Achieves Pilot-Scale Fully Automated Continuous Drug Substance Production

Stock News
·
Aug 14

Wuxi Biologics (Cayman) Stock Rises 1.2% in Hong Kong

Dow Jones
·
Aug 11

Wuxi Biologics (Cayman) Stock Sheds 5.1% in Hong Kong

Dow Jones
·
Aug 07

Wuxi Biologics (Cayman) Stock Rallies 2.0% in Hong Kong

Dow Jones
·
Aug 05

WuXi Biologics Expands Global Network with New Modular Facility in Singapore to Boost Biologics Manufacturing Capacity

Reuters
·
Jul 29

Wuxi Biologics (Cayman) Stock Advances 1.6% in Hong Kong

Dow Jones
·
Jul 28

HK Movers | WuXi Biologics Jumps 8% as It Expects First-Half Net Profit to Increase By Over 56% YoY

Tiger Newspress
·
Jul 25

HK Movers | Pharma Outsourcing Stocks Rise on Sector Optimism

Tiger Newspress
·
Jul 25